Serina Therapeutics to present at H.C. Wainwright conference on Sept 11

Serina Therapeutics, Inc.

Interim CEO Steve Ledger to present at H.C. Wainwright 26th Annual Global Investment Conference.
Presentation scheduled for September 11, 2024 at 12:00 p.m. ET.
Live webcast available via Investor section of Serina's website; replay available for limited time.
Serina is a clinical-stage biotech developing POZ Platform drug delivery technology.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.